According to the new research report published by Precedence Research, titled “Breast Biopsy Devices Market (By Product: Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Others; By Guidance: Image-Guided Biopsy, Mammography-guided Stereotactic Biopsy, Ultrasound-guided Biopsy, MRI-guided Biopsy, Other Guidance Techniques, Liquid Biopsy, NGS-based Biopsy, PCR-based Biopsy, Microarray-based Biopsy; By Type) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030 (By Product: Traditional, Advanced; By Application: Pottery, Tiles, Abrasives, Sanitary wave, Bricks & pipes, Others; By End User: Medical, Industrial, Building & Construction, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030”, the global breast biopsy devices market size is expected to be worth around US$ 4.6 billion by 2030 and is poised to record a yearly growth rate of 5.67% from 2022 to 2030. The study investigates several elements and their consequences on the growth of the all-wheel drive market.
This report focuses on breast biopsy devices market volume and value at the global level, regional level and company level. From a global perspective, this report represents the overall breast biopsy devices market size by analysing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, the Middle East & Africa, Latin America, etc.
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2402
The study also provides important advancements in organic and inorganic growth strategies in the worldwide breast biopsy devices market. A lot of corporations are prioritizing new launches, product approvals, and other business expansion techniques. In addition, the report offers profiles of breast biopsy devices market firms and market strategies. Furthermore, the research focuses on top industry participants, providing information such as company profiles, components and services offered, recent financial data, and key developments.
Breast Biopsy Devices Market Report Scope
| Report Coverage | Details |
| Market Size in 2022 | USD 2.96 Billion |
| Market Size by 2030 | USD 4.6 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 5.67% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered |
|
Also read: Dermatology CRO Market Size to Worth US$ 8.7 Billion by 2030
Market Key Players
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the breast biopsy devices market.
Some of the prominent players in the breast biopsy devices market include
- Cook Medical Incorporated
- Becton, Dickinson and Company
- Devicor Medical Products Inc.
- C.R. Bard, Inc., Hologic Inc
- Argon Medical Devices
- Planmed OY
- Encapsule Medical Devices LLC
- Ethicon Endo-Surgery (Johnson and Johnson)
Breast Biopsy Devices Market Segmentations
By Product
- Biopsy Needles
- Guidance Systems
- Biopsy Tables
- Localization Wires
- Assay Kits
- Liquid Biopsy Instruments
- Others
By Guidance
- Image-Guided Biopsy
- Mammography-guided Stereotactic Biopsy
- Ultrasound-guided Biopsy
- MRI-guided Biopsy
- Other Guidance Techniques
- Liquid Biopsy
- NGS-based Biopsy
- PCR-based Biopsy
- Microarray-based Biopsy
By Type
- Needle Breast Biopsy
- Core Needle Biopsy (CNB)
- Fine Needle Aspiration Biopsy (FNAB)
- Vacuum-assisted Biopsy (VAB)
- Open Surgical Breast Biopsy
- Excisional
- Incisional
- Liquid Breast Biopsy
- Circulating Tumor Cells
- Circulating Tumor DNA (CtDNA)
- Other Biomarkers
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Report Objectives
- To define, segment, and project the global market size for breast biopsy devices market
- To understand the structure of the market by identifying its various sub-segments
- To provide detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To analyse the micro-markets, with respect to individual growth trends, future prospects, and their contributions to the total market
- To project the size of the market and its submarkets, in terms of value, with respect to global. (along with their respective key countries)
- To profile key players and comprehensively analyse their core competencies
- To understand the competitive landscape and identify major growth strategies adopted by players across the globe.
- To analyse the competitive developments such as expansions & investments, new product launches, mergers & acquisitions, joint ventures, and agreements
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Breast Biopsy Devices Market
5.1. COVID-19 Landscape: Breast Biopsy Devices Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Breast Biopsy Devices Market, By Product
8.1. Breast Biopsy Devices Market, by Product, 2022-2030
8.1.1 Biopsy Needles
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Guidance Systems
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Biopsy Tables
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Localization Wires
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Assay Kits
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Liquid Biopsy Instruments
8.1.6.1. Market Revenue and Forecast (2017-2030)
8.1.7. Others
8.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Breast Biopsy Devices Market, By Guidance
9.1. Breast Biopsy Devices Market, by Guidance, 2022-2030
9.1.1. Image-Guided Biopsy
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Mammography-guided Stereotactic Biopsy
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Mammography-guided Stereotactic Biopsy
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. MRI-guided Biopsy
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Other Guidance Techniques
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Liquid Biopsy
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. NGS-based Biopsy
9.1.7.1. Market Revenue and Forecast (2017-2030)
9.1.8. PCR-based Biopsy
9.1.8.1. Market Revenue and Forecast (2017-2030)
9.1.9. Microarray-based Biopsy
9.1.9.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Breast Biopsy Devices Market, By Type
10.1. Breast Biopsy Devices Market, by Type, 2022-2030
10.1.1. Needle Breast Biopsy
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Core Needle Biopsy (CNB)
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Fine Needle Aspiration Biopsy (FNAB)
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Vacuum-assisted Biopsy (VAB)
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Open Surgical Breast Biopsy
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Excisional
10.1.6.1. Market Revenue and Forecast (2017-2030)
10.1.7. Incisional
10.1.7.1. Market Revenue and Forecast (2017-2030)
10.1.8. Liquid Breast Biopsy
10.1.8.1. Market Revenue and Forecast (2017-2030)
10.1.9. Circulating Tumor Cells
10.1.9.1. Market Revenue and Forecast (2017-2030)
10.1.10. Circulating Tumor DNA (CtDNA)
10.1.10.1. Market Revenue and Forecast (2017-2030)
10.1.11. Other Biomarkers
10.1.11.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Breast Biopsy Devices Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.1.3. Market Revenue and Forecast, by Type (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.1.4.3. Market Revenue and Forecast, by Type (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Type (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.2.3. Market Revenue and Forecast, by Type (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.2.4.3. Market Revenue and Forecast, by Type (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Type (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Type (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Type (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.3.3. Market Revenue and Forecast, by Type (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.3.4.3. Market Revenue and Forecast, by Type (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Type (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Type (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Type (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.4.3. Market Revenue and Forecast, by Type (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.4.4.3. Market Revenue and Forecast, by Type (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Type (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Type (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Type (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.5.3. Market Revenue and Forecast, by Type (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.5.4.3. Market Revenue and Forecast, by Type (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Guidance (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Type (2017-2030)
Chapter 12. Company Profiles
12.1. Cook Medical Incorporated
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Becton, Dickinson and Company
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Devicor Medical Products Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. C.R. Bard, Inc., Hologic Inc
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Argon Medical Devices
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Planmed OY
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Encapsule Medical Devices LLC
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Ethicon Endo-Surgery (Johnson and Johnson)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global breast biopsy devices market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for breast biopsy devices are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
